methylprednisolone and Diabetes Insipidus, Neurogenic

methylprednisolone has been researched along with Diabetes Insipidus, Neurogenic in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (40.00)	29.6817
2010's	1 (20.00)	24.3611
2020's	2 (40.00)	2.80

Authors

Authors	Studies
Asada, T; Otsuka, F; Sasaki, R; Senda, M; Takenoshita, S; Terada, S; Yamada, N; Yamamoto, K	1
Lu, X; Wang, L; Wang, Z; Xiao, Z; Zhou, Y; Zhu, L	1
Bonfá, E; Deveza, LM; Neves, EF; Pasoto, SG; Pereira, SL; Seguro, LP	1
Jaussaud, M; Léon, A; Lepouse, C; Murat, O; Perrier, S; Petit, JS	1
Amato, L; Coates, PS; Coates, PT; Li, JY; Mahadevan, K; Phillips, PJ; Yong, TY	1

Reviews

1 review(s) available for methylprednisolone and Diabetes Insipidus, Neurogenic

Article	Year
Pituitary involvement in Wegener's granulomatosis. Pituitary, 2008, Volume: 11, Issue:1 Topics: Adult; Antidiuretic Agents; Cyclophosphamide; Deamino Arginine Vasopressin; Diabetes Insipidus, Neurogenic; Drug Therapy, Combination; Glucocorticoids; Granulomatosis with Polyangiitis; Humans; Hypopituitarism; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Methylprednisolone; Pituitary Function Tests; Pituitary Gland; Recurrence; Treatment Outcome	2008

Article

Year

Pituitary involvement in Wegener's granulomatosis.

Pituitary, 2008, Volume: 11, Issue:1

Topics: Adult; Antidiuretic Agents; Cyclophosphamide; Deamino Arginine Vasopressin; Diabetes Insipidus, Neurogenic; Drug Therapy, Combination; Glucocorticoids; Granulomatosis with Polyangiitis; Humans; Hypopituitarism; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Methylprednisolone; Pituitary Function Tests; Pituitary Gland; Recurrence; Treatment Outcome

2008

Other Studies

4 other study(ies) available for methylprednisolone and Diabetes Insipidus, Neurogenic

Article	Year
Secondary autoimmune hypothalamitis with severe memory impairment 7 years after the onset of diabetes insipidus due to lymphocytic hypophysitis: a case report. BMC neurology, 2022, Sep-29, Volume: 22, Issue:1 Topics: Autoimmune Hypophysitis; Diabetes Insipidus; Diabetes Insipidus, Neurogenic; Diabetes Mellitus; Female; Humans; Hypopituitarism; Magnetic Resonance Imaging; Memory Disorders; Methylprednisolone; Middle Aged	2022
Successful management and treatment of SLE-associated hypophysitis. Immunologic research, 2020, Volume: 68, Issue:2 Topics: Achlorhydria; Adult; Cyclophosphamide; Deamino Arginine Vasopressin; Diabetes Insipidus, Neurogenic; Female; Hormones; Humans; Hypogonadism; Hyponatremia; Hypophysitis; Lupus Erythematosus, Systemic; Methylprednisolone; Treatment Outcome; Young Adult	2020
Longitudinal Extensive Transverse Myelitis and Central Diabetes Insipidus: A Severe Flare of Systemic Lupus Erythematosus. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2017, Volume: 23, Issue:2 Topics: Antirheumatic Agents; Brain; Cyclophosphamide; Diabetes Insipidus, Neurogenic; Diagnosis, Differential; Female; Humans; Lupus Erythematosus, Systemic; Magnetic Resonance Imaging; Methylprednisolone; Myelitis, Transverse; Patient Acuity; Plasma Exchange; Spinal Cord; Symptom Flare Up; Treatment Outcome; Young Adult	2017
[Headaches in a 21-year-old man with Goodpasture disease]. Annales francaises d'anesthesie et de reanimation, 2009, Volume: 28, Issue:9 Topics: Anti-Glomerular Basement Membrane Disease; Anticoagulants; Chondroitin Sulfates; Combined Modality Therapy; Dermatan Sulfate; Diabetes Insipidus, Neurogenic; Disseminated Intravascular Coagulation; Enoxaparin; Fatal Outcome; Headache; Heparin; Heparitin Sulfate; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Plasma Exchange; Platelet Factor 4; Sinus Thrombosis, Intracranial; Thrombocytopenia; Young Adult	2009